de la Fouchardière, C.; Gamradt, P.; Chabaud, S.; Raddaz, M.; Blanc, E.; Msika, O.; Treilleux, I.; Bachy, S.; Cattey-Javouhey, A.; Guibert, P.;
et al. A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. J. Pers. Med. 2022, 12, 623.
https://doi.org/10.3390/jpm12040623
AMA Style
de la Fouchardière C, Gamradt P, Chabaud S, Raddaz M, Blanc E, Msika O, Treilleux I, Bachy S, Cattey-Javouhey A, Guibert P,
et al. A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Journal of Personalized Medicine. 2022; 12(4):623.
https://doi.org/10.3390/jpm12040623
Chicago/Turabian Style
de la Fouchardière, Christelle, Pia Gamradt, Sylvie Chabaud, Maxime Raddaz, Ellen Blanc, Olivier Msika, Isabelle Treilleux, Sophie Bachy, Anne Cattey-Javouhey, Pierre Guibert,
and et al. 2022. "A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3" Journal of Personalized Medicine 12, no. 4: 623.
https://doi.org/10.3390/jpm12040623
APA Style
de la Fouchardière, C., Gamradt, P., Chabaud, S., Raddaz, M., Blanc, E., Msika, O., Treilleux, I., Bachy, S., Cattey-Javouhey, A., Guibert, P., Sarabi, M., Rochefort, P., Funk-Debleds, P., Coutzac, C., Ray-Coquard, I., Peyrat, P., Meeus, P., Rivoire, M., Dupré, A.,
& Hennino, A.
(2022). A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Journal of Personalized Medicine, 12(4), 623.
https://doi.org/10.3390/jpm12040623
